NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
1-Year Return
24.46%
This Quarter Return
+16.38%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$8.08B
AUM Growth
+$2.81B
(+53%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
26.98%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
626
New
29
Increased
519
Reduced
46
Closed
10
Top Buys
| 1 |
NVIDIA
NVDA
|
$166M |
| 2 |
Microsoft
MSFT
|
$162M |
| 3 |
Apple
AAPL
|
$126M |
| 4 |
Broadcom
AVGO
|
$86.4M |
| 5 |
Amazon
AMZN
|
$85.6M |
Top Sells
| 1 |
Clean Harbors
CLH
|
$4.34M |
| 2 |
Rockwell Automation
ROK
|
$4.29M |
| 3 |
Vulcan Materials
VMC
|
$4.24M |
| 4 |
Applied Industrial Technologies
AIT
|
$3.95M |
| 5 |
ATI
ATI
|
$3.93M |
Sector Composition
| 1 | Technology | 37.54% |
| 2 | Communication Services | 11.03% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Healthcare | 8.06% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Relay Therapeutics
RLAY
$690M
| $336K | ﹤0.01% |
97,150
+8,040
| +9% | +$27.8K |
|
577
Teledyne Technologies
TDY
$25.6B
| $334K | ﹤0.01% |
652
| – | – |
|
578
Corpay
CPAY
$22.6B
| $323K | ﹤0.01% |
972
+6
| +0.6% | +$1.99K |
|
579
Cullinan Oncology
CGEM
$408M
| $321K | ﹤0.01% |
42,692
+3,528
| +9% | +$26.6K |
|
580
STAG Industrial
STAG
$6.86B
| $321K | ﹤0.01% |
+8,841
| New | +$321K |
|
581
Ulta Beauty
ULTA
$23.7B
| $319K | ﹤0.01% |
681
| – | – |
|
582
Deckers Outdoor
DECK
$18.4B
| $310K | ﹤0.01% |
3,010
+12
| +0.4% | +$1.24K |
|
583
Starwood Property Trust
STWD
$7.52B
| $306K | ﹤0.01% |
+15,267
| New | +$306K |
|
584
NVR
NVR
$23.2B
| $303K | ﹤0.01% |
41
| – | – |
|
585
First Industrial Realty Trust
FR
$6.89B
| $301K | ﹤0.01% |
+6,254
| New | +$301K |
|
586
Vornado Realty Trust
VNO
$7.66B
| $300K | ﹤0.01% |
+7,835
| New | +$300K |
|
587
VeriSign
VRSN
$25.9B
| $281K | ﹤0.01% |
973
+6
| +0.6% | +$1.73K |
|
588
Campbell Soup
CPB
$9.74B
| $279K | ﹤0.01% |
9,118
+1,789
| +24% | +$54.8K |
|
589
Rithm Capital
RITM
$6.66B
| $279K | ﹤0.01% |
24,727
+13,537
| +121% | +$153K |
|
|
MREO
590
Mereo BioPharma
MREO
$275M
| $278K | ﹤0.01% |
102,583
-552,083
| -84% | -$1.5M |
|
|
AUTL
591
Autolus Therapeutics
AUTL
$386M
| $274K | ﹤0.01% |
120,388
+9,960
| +9% | +$22.7K |
|
592
Nuvation Bio
NUVB
$1.17B
| $272K | ﹤0.01% |
+139,648
| New | +$272K |
|
593
Healthcare Realty
HR
$6.15B
| $266K | ﹤0.01% |
+16,782
| New | +$266K |
|
594
Labcorp
LH
$22.9B
| $255K | ﹤0.01% |
973
+6
| +0.6% | +$1.58K |
|
595
Brown-Forman Class B
BF.B
$13.3B
| $254K | ﹤0.01% |
9,445
+1,789
| +23% | +$48.1K |
|
596
AnaptysBio
ANAB
$590M
| $253K | ﹤0.01% |
+11,404
| New | +$253K |
|
597
Catalyst Pharmaceutical
CPRX
$2.42B
| $246K | ﹤0.01% |
11,352
| – | – |
|
598
F5
FFIV
$18.1B
| $245K | ﹤0.01% |
831
+4
| +0.5% | +$1.18K |
|
599
Axsome Therapeutics
AXSM
$6.21B
| $243K | ﹤0.01% |
2,327
| – | – |
|
600
Molina Healthcare
MOH
$9.26B
| $240K | ﹤0.01% |
806
+4
| +0.5% | +$1.19K |
|